Member Info for WaspsFan

Roguemale does that 375p price pre-Covid reflect that we have had a dilution since then as well as a consolidation? If not would is an apples for apples comparison?

Opu, a great read and thanks, but if this doesn't translate into a positive trading update then it doesn't pass the ''so what'' test. Any idea when that trading update is?

I agree Facester. The Trading Statement when it comes will be the defining moment of Mr Murdoch's career one way or another.

Opulentia, you are like a one man.woman PR machine pumping up MCRO!! I just hope the Trading Update, when it comes, is as bullish as your posts! It needs to be. I have 30 odd different shares in my portfolio, MCRO is my worst performer this year by a country mile....

Pity we are down over 4% when the FTSE 250 is up over 2%. Hope this isn't as a result of knowledge of a trading statement tomorrow...

Just over a month ago a significant amount of Directors put their hands in their pockets to buy. This probably says more about the positive outlook for the company than today's trading statement. On Covid the CEO has always been clear to point out that testing should not come at a price that impacts the core business, and in my view he is right. In the light of Fauci's comment on the Andrew Marr show yesterday, the government's own advisors recent statements, and news today about hospitals gearing up on the stockpiles of vaccine, a vaccine itself is clearly just around the corner. Whilst this won't put an immediate end to testing and testing may well continue well into 2021 in some form, it will at some point be scaled down. So in my view YGEN are deploying the go to market strategy.

Also, and I feel of great importance is a comment made by the Business Development Director on the webinar last week. In the Q&A someone asked whether YGEN is involved in the government's Moonshot programme. His response was was that YGEN is in discussions with local and national government and hope to be part of the programme in, I quote, ''the very near future''. So I assume this was not included in today's announcement. Thoughts?

Notaflipper - great post. Puts a real sense of perspective on the big picture.

One supposes there has to be a reason for the delay in the trading update given the corresponding announcement date in 2018 and 2019. Let's hope it is for positive reasons. Nothing happens without reason as the old saying goes.

notaflipper thank you for your insights. I wonder what you have written fits against BJ's Moonshot project around mass testing which he updated us on in his government briefing today. You have to feel that Yourgene have a part to play in that even if it is a relatively small one.

No mention of YGEN specifically but this FT article is in their backyard - apologies if it has already been posted. Rapidly growing market.

https://www.ft.com/content/17c5a06e-7987-415f-ad60-78102535a12f

Odds on a Trading Statement in the morning I reckon. 3 trading days with RNS's in the lead up that did nothing for the price other than hold it up. A 'Covid' related statement will put YGEN firmly into the Covid stock category which is really what drives the share price of progressive stocks currently. We will see.

What I would like to understand most of all is to what extent YGEN will be supporting the government testing strategy. That is what in the short term at least will capture market imagination most IMO. The private sector is a nice bolt-on, and I know is their main focus currently. Hopefully next week will give us some insights into the big picture.

Does anyone in this stock have level 2, if so can you offer occasional updates on the position please?

If this morning's results and acquisition don't capture market imagination nothing will! Operating at a discount to its peers and below the radar of its higher profile counterparts, to me this morning's announcements show a step-up in the company's growth both in terms of current business and ambitious future strategy. Given it is a booming market as a result of the pandemic, definitely a share to be tucked away in the bottom drawer.

That can't be right surely? 40p on the share price for 30K monthly tests equates to approximately an additional £280m market cap compared to where we are now. That is a huge figure and triple the £140M of today.

Thank you for the detailed response Steve (and the link). Much appreciated.

I am trying to understand whether there is a difference between the amount of Clarigene test kits that are manufactured and to what extent the actual analysis to the tests will be done by Yougene themselves. So from the recent AGM presentation and Q&A Session does anyone please have a view on:

1) Clarigene Test Kits: How many can be manufactured a day now? And what would be the maximum manufacturing capacity over time?
2) From these test kits how many can Yougene analyse themselves daily currently? And how much could that figure be increased in the future?
3) Was there any mention of timescales for the NHS to approve use of the Clarigene diagnostic kit, and if so would the results be analysed by Yougene or another third party?

I believe the Indices are re-aligned after close of trading tomorrow not when the market opens.

I see nothing untoward, stocks in unfashionable sectors like media are back to where they were in late March. Look at WPP you will see the exact same bell shaped curve. Just sit tight and ride the storm. Shades of 2008 and the dotcom bubble in 2000. Any money you invest now will come good once the pandemic passes and ITV should comfortably double from here with an 18 month view. Any bid or other material development that occurs in the meantime is just a bonus.

I agree with that and with a 7% yield it is like having money in a building society with 7% interest and capital growth to boot. That fact won't be lost on the senior execs who have bought shares in the last 48 hours. Where else would you get that sort of return these days?